DrugPatentWatch Database Preview
Corcept Therap Company Profile
» See Plans and Pricing
What is the competitive landscape for CORCEPT THERAP, and what generic alternatives to CORCEPT THERAP drugs are available?
CORCEPT THERAP has one approved drug.
There are sixteen US patents protecting CORCEPT THERAP drugs.
There are thirty-one patent family members on CORCEPT THERAP drugs in eleven countries.
Summary for Corcept Therap
| International Patents: | 31 |
| US Patents: | 16 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Corcept Therap: | See patent lawsuits for Corcept Therap |
Drugs and US Patents for Corcept Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corcept Therap | KORLYM | mifepristone | TABLET;ORAL | 202107-001 | Feb 17, 2012 | AB | RX | Yes | Yes | 9,943,526 | Start Trial | Start Trial | |||
| Corcept Therap | KORLYM | mifepristone | TABLET;ORAL | 202107-001 | Feb 17, 2012 | AB | RX | Yes | Yes | 10,500,216 | Start Trial | Start Trial | |||
| Corcept Therap | KORLYM | mifepristone | TABLET;ORAL | 202107-001 | Feb 17, 2012 | AB | RX | Yes | Yes | 10,495,650 | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Corcept Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Singapore | 11201907854V | Start Trial |
| Israel | 269009 | Start Trial |
| Mexico | 2018001803 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
